PGxAI
About PGxAI
PGxAI is a healthcare AI company at the forefront of precision medicine, specifically focusing on pharmacogenomics. The company develops an artificial intelligence-powered platform designed to optimize patient outcomes by personalizing drug selection, dosing, and interaction management based on an individual’s unique genetic makeup. Their platform utilizes advanced AI and data analytics to support clinical decision-making, accelerate drug development, and improve success rates through targeted patient stratification and real-time analytics.
For physicians, PGxAI offers a configurable clinician-facing platform that provides evidence-linked clinical decision support. It helps licensed healthcare professionals review relevant medication-safety and pharmacogenomic information in a structured workflow. This includes drug-drug interaction review, identification of contraindications and precautions, and retrieval of pharmacogenomic guidance when interpreted results are available. The platform integrates with existing EHR and hospital workflows, delivering real-time clinical decision support and translating complex genetic data into clear, actionable clinical guidance. This aims to empower physicians to evaluate a wider range of treatment options, reduce the likelihood of serious adverse reactions, and move towards precision prescribing at scale.
Focus Areas
Business Intelligence
| Key Investors | ATEM Capital, Creative Destruction Lab, InterSystems Ventures, Najashi Holding |
| Partnerships | InterSystems, NVIDIA, Google, Microsoft, Sequencing.com, Najashi Holding, Lean Business Services, Biostrand (a subsidiary of IPA) |
| Technology | AI-powered multiomics platform, cloud-native, HPC technology, VectorSearch, GenAI, InterSystems IRIS for Health, InterSystems HealthShare, InterSystems TrakCare |
What Physicians Need to Know
For physicians, PGxAI offers a powerful tool to move beyond 'trial-and-error' prescribing by providing personalized, genetic-based insights into drug efficacy and safety. This can lead to proactive dosage adjustments, consideration of safer alternatives, and a reduction in adverse drug reactions. The platform integrates seamlessly into existing EHR and hospital workflows, delivering real-time clinical decision support without disrupting care processes. This allows you to focus on patient care with a wider range of options and reduced likelihood of serious adverse events. PGxAI's reports are designed to be 'plug-and-play' for genomic labs, offering new revenue streams while delivering measurable benefits for patients.
PGxAI's technology is built on robust partnerships with leading technology providers including NVIDIA, InterSystems, Google, and Microsoft. They integrate with InterSystems' HealthShare to deliver real-time clinical decision support directly into EHR and hospital workflows. The platform is also built on InterSystems IRIS for Health and FHIR-native TrakCare standards, allowing it to ingest longitudinal data directly from EHRs, LIMS, and wearable devices. PGxAI's reports seamlessly integrate with major reporting formats from clinically actionable consumer genetic testing services, allowing for easy upload of genetic data.
What the Web Says
PGxAI, a company specializing in pharmacogenomics (PGx) interpretation and clinical decision support, generally receives positive feedback for its product's utility in integrating PGx data into patient care. While specific product reviews on major platforms like G2 or Capterra are limited, the company's focus on actionable insights and ease of integration is highlighted. Employer reviews are not readily available on Glassdoor or similar platforms.
Overall: PositiveStrengths
- Provides actionable pharmacogenomic insights
- Aids in clinical decision support for medication management
- Focus on improving patient outcomes through personalized medicine
- Likely integrates with existing EHR systems (implied by clinical utility)
- Addresses a growing need in precision medicine
- Simplifies complex PGx data for clinicians
Limitations
- Limited public product reviews on major platforms (G2, Capterra)
- Lack of readily available employer reviews on Glassdoor
- Specific pricing information not easily accessible
- Adoption challenges in healthcare due to new technology integration
- Potential for data privacy concerns (common in healthcare IT)
- Reliance on accurate and up-to-date genetic testing data
Based on reviews from: PGxAI Website, Healthcare IT industry discussions (general), Precision medicine articles
Last updated: 2026-07-10
Videos
News, demos, and interviews about PGxAI.
Videos load interactively. If none appear, search YouTube for PGxAI →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]